Itron (ITRI) | News Based Sentiment Analysis

• On October 1, 2025, Itron director Sheri Savage acquired 631 shares of common stock as compensation for her board service, with 223 shares representing prorated service for the third quarter of 2025. This insider activity, while not a cash transaction, signals confidence from a company director and increases her stake to 631 shares.
• Itron is facing projected headwinds in the short term, with analysts estimating an Earnings Per Share (EPS) of $1.48 for the upcoming quarter, a 19.57% decrease year-over-year. Revenue is also expected to decline by 6.34% to $576.45 million compared to the same quarter last year.
• Despite these short-term projections, the full-year outlook remains more optimistic, with Zacks Consensus Estimates forecasting earnings of $6.07 per share, an 8.01% increase from the preceding year. Full-year revenue is estimated at $2.37 billion, representing a 2.76% decrease.
• Itron currently holds a Zacks Rank of #2 (Buy) as of October 4, 2025, indicating a favorable outlook from analysts. Its Forward P/E ratio of 20.35 is a discount compared to the industry average of 23.17, and its PEG ratio of 0.68 is lower than the industry average of 2.68, suggesting potential undervaluation.
• Itron's stock demonstrated positive momentum on October 4, 2025, closing at $125.44, up 1.5% from the previous day, outpacing the S&P 500's 0.01% gain. Over the past month, Itron shares have increased by 2.04%, though the Computer and Technology sector and the S&P 500 have seen larger gains of 10.49% and 4.83% respectively.

The Investment Story: Itron is navigating a period of short-term revenue and earnings decline, but maintains a positive long-term outlook supported by analyst ratings and a favorable valuation. The recent stock performance shows some positive momentum, though it hasn't kept pace with broader market gains.

What It Means for Investors: Investors should consider the short-term challenges reflected in the lowered EPS and revenue estimates, but also recognize the potential for long-term growth indicated by the full-year forecasts and the Zacks 'Buy' rating. The relatively low P/E and PEG ratios suggest the stock may be undervalued.

Looking Ahead: Investors should closely monitor Itron's upcoming earnings report to see if the company can meet the projected EPS of $1.48 and revenue of $576.45 million. Further analyst commentary and any revisions to full-year guidance will also be key indicators.

The Bottom Line: Itron presents a mixed investment picture. While facing near-term headwinds, the company's favorable analyst rating, discounted valuation, and positive long-term earnings projections suggest potential for future growth, making it a stock to watch closely.